This study is testing whether a new type of cell therapy called Descartes-08 is safe and feasible for people with systemic lupus erythematosus (SLE). It involves 6 adult patients whose lupus symptoms remain active despite trying multiple standard medications. The main goal is to …
Phase: PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC